The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing examining how covered entities use the 340B Drug Pricing Program. Established by Congress in 1992, the program mandates that drug manufacturers provide outpatient drugs to eligible health care organizations at reduced prices to remain eligible for reimbursements through entitlement programs such as Medicaid and Medicare. Witnesses at the hearing included hospital, health center and HIV care providers, who shared how the 340B program benefits the patients and communities they serve. “For 25 years, the 340B Drug Pricing Program has been critical in helping hospitals stretch scarce federal resources to expand and improve access to lifesaving prescription drugs and comprehensive health for our nation’s most vulnerable patients,” AHA Executive Vice President Tom Nickels said, commenting on the hearing. “This program is as important as ever given the skyrocketing prescription drug price increases that have presented hospitals and their patients with remarkable challenges. Additionally, the 340B program constitutes less than 2.8% of the $457 billion in annual drug purchases made in the U.S., and does not cost the government or taxpayers a single penny. For all these reasons, America’s hospitals and health systems will continue to advocate for this vitally important program that helps improve patient care in communities across the country.”

Related News Articles

Headline
Hospitals in states that impose Medicaid work requirements could see reduced Medicaid revenues and operating margins and increased uncompensated care costs,…
Headline
About 34 percent of uninsured U.S. adults did not take their medication as prescribed in 2017 in order to reduce their prescription drug costs, according to a…
Headline
The Medicare Payment Advisory Commission Friday released its March report to Congress.
Headline
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…
Headline
he Medicaid and CHIP Payment and Access Commission today released its March 2019 report to Congress, which recommends Congress phase in the Affordable Care Act…
Headline
The Centers for Medicare & Medicaid Services today